Medium due to technology 中因科技

  • Home

  • Gene therapy

    • Drug development

    • Industrialization of pharmaceuticals

    • Quality assurance system

    • Clinical trial

  • News

  • About us

    • Company

    • History

    • Honor

    • Publications

  • CHIGENOVO LAB

中文 /EN

400-6006223

Confirm
GENE THETAPY

GENE THETAPY

Drug development

Industrialization of pharmaceuticals

Quality assurance system

Clinical trial

Quality assurance system

Based on lS09001/14001/45001 and China's "Drug Administration Law (DAL)"and "Biosafety Law (BL)", the company has formulated overall management policies and objectives, standardized the quality and safety of various activities carried out by the company, and gave maximum consideration to the impact on the environment, employee occupational health and other aspects, and has passed relevant certifications.

 

According to ICHQ10, China NMPA and other relevant international and domestic laws and regulations, carry out R&D and production management during the product life cycle and establish relevant management systems to ensure the legal compliance of R&D、non-clinical research, clinical research and production management activities.


Medium cause

CHIGENOVO Co., Ltd. is an ophthalmic gene therapy company, a national high-tech enterprise focusing on genetic diagnosis of genetic eye diseases and the development of gene therapy drugs. It is committed to providing "one-stop" services for patients with genetic eye diseases.

HUATAO GROUP

Contact us


Telephone:400-6006223   010-82071936
Website:en.chinagene.cc
Address: Floor 4, Area D, Building 1, No.27 Life Garden Road, Zhongguancun Life Science Park, Changping District, Beijing

WeChat subscription account


Medium cause

Powered by www.300.cn | SEO

Business License